Profile
MDWD NVO VRTX REGN SGEN MRNA
Company Name MediWound Ltd. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Moderna, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $166.96M $573.09B $103.52B $97.86B $43.15B $41.68B
Employees 0.10K 63.37K 5.40K 13.45K 3.26K 5.60K
CEO Mr. Ofer Gonen B.Sc. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Stephane Bancel
Ratings
MDWD NVO VRTX REGN SGEN MRNA
Quant Rating Score 3 5 5 5 3 4
Quant Rating Neutral Strong Buy Strong Buy Strong Buy Neutral Buy
Trading
MDWD NVO VRTX REGN SGEN MRNA
Last Close $17.59 $126.16 $400.76 $906.54 $228.74 $108.85
High 52 $18.28 $199.54 $446.08 $993.35 $228.9 $137.75
Low 52 $7.18 $87.78 $323.3 $692.45 $187.64 $69.51
Price vs. 52 Week High -3.77 % -36.77 % -10.16 % -8.74 % -0.07 % -20.98 %
Price vs. 52 Week Low 144.99 % 43.72 % 23.96 % 30.92 % 21.9 % 56.6 %
Total Return
MDWD NVO VRTX REGN SGEN MRNA
1 Month Return 11.12 % -2.24 % -3.67 % -5.68 % 0 % -1.39 %
3 Month Return 36.57 % 19.38 % -6.79 % -4.46 % 0 % 5.87 %
6 Month Return 119.6 % 29.49 % 10.39 % 13.74 % 5.59 % 41.81 %
9 Month Return 87.33 % -22.27 % 11.93 % 24.2 % 17.83 % -10.68 %
YTD Return 72.96 % 21.95 % -1.51 % 3.22 % 0 % 9.45 %
1 Year Return 48.44 % -25.16 % 20.74 % 14.81 % 12.57 % -19.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MDWD NVO VRTX REGN SGEN MRNA
Dividend Yield Percentage (TTM) - 1.44 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -1.51 % 1.54 % 13.69 % 5.88 % -3.35 % -4.41 %
Dividend Per Share (TTM) - 1.81 % - - - -
Payout Ratio (TTM) - 37.96 % - - - -
Growth
MDWD NVO VRTX REGN SGEN MRNA
Asset Growth 32.88 % 30.35 % 25.23 % 13.23 % -1.21 % -28.74 %
Gross Profit Growth -77.61 % 32.32 % 9.25 % 6.49 % 22.93 % -85.12 %
Revenue Growth -29.48 % 31.26 % 10.17 % 7.76 % 24.65 % -64.94 %
Revenue 3 Year -63.01 % 90.51 % 59.87 % 56.27 % 91.84 % 2354.12 %
Revenue 5 Year 136.11 % 124.2 % 218.58 % 97.36 % 215.48 % 1070.62 %
Revenue 10 Year - 66.11 % 608.27 % 509.63 % 494.04 % 6447.35 %
EBIT Growth -85.75 % 37.11 % -12.94 % -14.6 % 10.13 % -145 %
Net Income Growth 65.73 % 50.71 % 8.96 % -8.87 % 9.51 % -156.37 %
Net Income 3 Yeari Growth Per Share 69.87 % 106.79 % 34.59 % 13.92 % -764.83 % -529.35 %
Net Income 5 Yeari Growth Per Share -173.05 % 133.86 % 70.33 % 63.31 % -276.93 % -160.17 %
Net Income 10 Yeari Growth Per Share 85.89 % 98.61 % 809.6 % 811.34 % -624.16 % -2046.03 %
Operating Income Growth -85.75 % 37.11 % -12.94 % -14.6 % 10.13 % -145 %
Operating Cash Flow Growth (CFG) 28.33 % 38.06 % -14.35 % -8.39 % 9.07 % -162.6 %
Operating 3 Year CFG 46.78 % 118.29 % 9.63 % 77.63 % -148.34 % -253.42 %
Operating 5 Year CFG 69.88 % 163.51 % 174.78 % 111.31 % -195.86 % -100.11 %
Operating 10 Year CFG 71.79 % 150.92 % 5187.08 % 663.48 % -2622.09 % -4698.89 %
EPS Growth 80.92 % 52.28 % 8.33 % -8.54 % 10.81 % -158.04 %
EPS Diluted Growth 80.92 % 52.37 % 8.35 % -9.03 % 10.81 % -161.33 %
Book Value Per Share 60.18 % 29 % 25.58 % 14.4 % -9.83 % -21.18 %
Share Holder 3 Year Equity Growth Per Share 87.16 % 75.22 % 104.06 % 138.48 % 33.92 % 439.47 %
Share Holder 5 Year Equity Growth Per Share 51.34 % 121.9 % 291.14 % 199.46 % 220.81 % 92.24 %
Share Holder 10 Year Equity Growth Per Share 151.46 % 49.62 % 1030.79 % 1201.51 % 691.19 % 1519.81 %
Dividend Per Share Growth - 26.89 % - - - 59.65 %
Dividend 3 Year Growth Per Share - 64.4 % -100 % - - 3725.19 %
Dividend 5 Year Growth Per Share - 80.03 % -100 % - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 693.26 % 4.74 % 44.1 % 0.06 % -23.28 % 3.58 %
Free Cash Flow Growth -20.43 % 9.17 % -16.47 % -17.11 % 3.67 % -183.5 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
MDWD NVO VRTX REGN SGEN MRNA
Gross Profit Margin TTM 19.15 % 84.6 % 87.21 % 87.87 % 75.4 % 31.49 %
Return on Assets TTM -10.11 % 26.61 % 15.92 % 11.95 % -20.64 % -25.58 %
Return on Equity TTM -20.22 % 90.49 % 22.62 % 16.07 % -28.06 % -29.87 %
Return on Capital Employed TTM -27.46 % 70.82 % 19.82 % 13.65 % -29.5 % -27.51 %
Net Income Per EBT TTM 102.83 % 79.95 % 82.64 % 94.15 % 101.53 % 119.58 %
EBT Per Ebit TTM 42.75 % 102.05 % 115.19 % 103.76 % 93.47 % 92.99 %
EBIT Per Revenue TTM -81.76 % 44.16 % 38.53 % 30.85 % -34.37 % -61.88 %
Cash Flow To Debt Ratio TTM -143.85 % 403.27 % 437.57 % 169.97 % -475.96 % -250.84 %
Receivables Turnover TTM 4.23 3.09 6.31 2.31 3.64 6.34
Payables Turnover TTM 2.73 1.4 3.46 2.62 2.52 9.03
Inventory Turnover TTM 5.31 1.12 1.71 0.62 1.07 23.23
Fixed Asset Turnover TTM 117.33 % 255.34 % 679.28 % 316.35 % 471.71 % 257.71 %
Asset Turnover TTM 28.12 % 73.85 % 43.42 % 39.65 % 63.3 % 37.18 %
Operating Cash Flow Per Share TTM -1.05 24.39 13.73 43.1 -2.87 -8.18
Free Cash Flow Per Share TTM -1.74 15.68 12.72 35.77 -3.73 -10.04
Cash Per Share TTM 452.37 % 677.09 % 4354.48 % 10173.36 % 657.5 % 2258.27 %
Operating Cash Flow Sales Ratio TTM -51.66 % 46.89 % 35.84 % 35.02 % -23.48 % -45.52 %
Free Cash Flow Operating Cash Flow Ratio TTM 166.31 % 64.29 % 92.69 % 83.01 % 129.82 % 122.67 %
Cash Flow Coverage Ratios TTM -143.85 % 403.27 % 437.57 % 169.97 % -475.96 % -250.84 %
Price To Free Cash Flows Ratio TTM -10.4 56.92 31.57 25.66 -61.54 -10.9
Price To Operating Cash Flows Ratio TTM -16.8 35.96 29.2 21.04 -79.67 -13.3
Price Cash Flow Ratio TTM -16.8 35.96 29.2 21.04 -79.67 -13.3
Income Statement (TTM)
MDWD NVO VRTX REGN SGEN MRNA
Revenue $0.02B $232.26B $9.84B $13.12B $1.96B $6.75B
Gross Profit $0B $196.5B $8.58B $11.3B $1.55B $2.06B
Gross Profit Ratio 15.77% 84.6% 87.17% 86.16% 79.1% 30.52%
EBITDA $-0.01B $112.94B $3.93B $5.13B $-0.62B $-3.21B
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-4.71B
EPS Diluted -0.75 18.62 13.89 34.77 -3.3 -12.34
Balance Sheet (MRQ)
MDWD NVO VRTX REGN SGEN MRNA
Long Term Debt $0.01B $20.53B $0.72B $2.7B $0.04B $1.22B
Total Liabilities $0.03B $207.93B $5.15B $7.11B $0.87B $4.57B
Total Equity $0.03B $106.56B $17.58B $25.97B $2.8B $13.85B
Total Investments $0.03B $17.5B $3.45B $13.51B $1.42B $4.68B
Total Debt $0.01B $27.01B $0.81B $2.7B $0.04B $1.24B
Total Assets $0.07B $314.49B $22.73B $33.08B $3.67B $18.43B
Cash Flow Statement (TTM)
MDWD NVO VRTX REGN SGEN MRNA
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-4.71B
Inventory $-0B $-7.42B $-0.32B $-0.27B $-0.23B $0.75B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-0.45B $-3.12B
Capital Expenditure $-0.01B $-38.9B $-0.26B $-0.93B $-0.08B $-0.71B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.675
ABCL AbCellera Biologics Inc. 3.65
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 3.17
ABIO ARCA biopharma, Inc. 3.47
ABOS Acumen Pharmaceuticals, Inc. 3.19
ABSI Absci Corporation 4.45
ABUS Arbutus Biopharma Corporation 2.721
ABVC ABVC BioPharma, Inc. 1.58
ABVX Abivax SA American Depositary Shares 15.98
ACAD ACADIA Pharmaceuticals Inc. 16.32
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.8
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.7744
ACHV Achieve Life Sciences, Inc. 4.585
ACIU AC Immune SA 2.28
ACLX Arcellx, Inc. 51.38
ACRV Acrivon Therapeutics, Inc. Common Stock 8.455
ACST Acasti Pharma Inc. 2.9285
ETFs With Exposure to MDWD
Ticker ETF Name Weight Percentage Price
IWC iShares Micro-Cap ETF 0.0243 111.07
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.45 30.95
AIIQ AI Powered International Equity ETF 0.48 24.58
Unlock